http://www.bing.com/news/search?q=novo&FORM=BNFD&format=rssSearch resultshttp://www.bing.com/rsslogo.gifhttp://www.bing.com/news/search?q=novo&FORM=BNFD&format=rssCopyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a1308c176924765bc0b9fd9e2a4382f&url=https%3a%2f%2fwww.msn.com%2fen-us%2fmoney%2fcompanies%2fnovo-nordisk-ceo-says-the-drugmaker-is-more-active-than-ever-in-seeking-out-deals%2far-AA22wSLI&c=7170280949327654260&mkt=en-usNovo Nordisk CEO Mike Doustdar says the Ozempic and Wegovy maker is looking for deals more than ever before.Wed, 06 May 2026 08:56:08 GMTCNBC on MSNhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a1308c176924765bc0b9fd9e2a4382f&url=https%3a%2f%2fwww.msn.com%2fen-gb%2fhealth%2fother%2fema-backs-novos-wegovy-pill-first-oral-weight-loss-drug-for-europe%2far-AA23Pa20&c=9873727738459977898&mkt=en-usBy Bhanvi Satija and Puyaan Singh May 22 (Reuters) - The European Medicines Agency recommended approval of Novo Nordisk's weight-loss pill Wegovy, the regulator said on Friday, clearing the way for it ...Fri, 22 May 2026 10:38:00 GMTReuters on MSNhttp://www.bing.com/th?id=ORMS.7dd7e196dd31a06bcce30ed863277bad&pid=Newsw={0}&h={1}&c=1419201005http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a1308c176924765bc0b9fd9e2a4382f&url=https%3a%2f%2fseekingalpha.com%2fnews%2f4596414-novo-gets-eu-backing-higher-dose-wegovy-single-dose-pen&c=5513903562590347416&mkt=en-usNovo Nordisk (NVO) stock is in focus as the EU endorses a single-dose pen containing a 7.2 mg version of the company's popular obesity therapy Wegovy. Read more here.Fri, 22 May 2026 11:10:00 GMTSeeking Alphahttp://www.bing.com/th?id=ONUT.1oXzt6FT8WGbL5x-Oycr8g&pid=Newsw={0}&h={1}&c=14630420http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a1308c176924765bc0b9fd9e2a4382f&url=https%3a%2f%2fwww.msn.com%2fen-us%2fhealth%2fother%2feuropean-medicines-regulator-recommends-approval-for-novo-s-wegovy-pill%2far-AA23OIe6&c=8408753970411854376&mkt=en-usMay 22 (Reuters) - The European Medicines Agency recommended approval for Novo Nordisk's weight-loss pill Wegovy, the regulator said on Friday, clearing its path to become the first oral weight-loss ...Fri, 22 May 2026 03:51:05 GMTReuters on MSNhttp://www.bing.com/th?id=ONUT.DrFHg7jOn18JmM-kt3gSig&pid=Newsw={0}&h={1}&c=14800533http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a1308c176924765bc0b9fd9e2a4382f&url=https%3a%2f%2fwww.statnews.com%2f2025%2f07%2f29%2fnovo-nordisk-maziar-mike-doustdar-ceo-growth-outlook%2f&c=2084211262270285886&mkt=en-usElaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...Mon, 28 Jul 2025 17:00:00 GMTSTAThttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a1308c176924765bc0b9fd9e2a4382f&url=https%3a%2f%2fwww.fiercepharma.com%2fpharma%2fnovo-nordisk-offers-cheaper-wegovy-all-cash-paying-patients-retail-pharmacy&c=710118124622977041&mkt=en-usNovo Nordisk has quickly expanded its discounted Wegovy program, now offering all eligible cash-paying customers its popular weight-loss med at $499 per month. Novo had only launched the cheaper ...Mon, 24 Mar 2025 03:15:00 GMTFiercePharmahttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a1308c176924765bc0b9fd9e2a4382f&url=https%3a%2f%2fwww.msn.com%2fen-us%2fmoney%2ftopstocks%2fis-novo-nordisks-rebound-for-real-or-just-a-head-fake%2far-AA237sBT&c=4682556053694464944&mkt=en-usThe worst might be in the rearview mirror.Wed, 13 May 2026 11:15:00 GMTThe Motley Fool on MSNhttp://www.bing.com/th?id=ORMS.8a3a928a0752759d7a3c1167274d8878&pid=Newsw={0}&h={1}&c=141200800http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a1308c176924765bc0b9fd9e2a4382f&url=https%3a%2f%2fwww.fiercepharma.com%2fpharma%2fnovo-rekindles-heart-failure-hopes-semaglutide-new-pooled-analysis&c=17336786625123823155&mkt=en-usAfter a regulatory hiccup earlier this month, Novo Nordisk’s heart failure ambitions for its obesity star Wegovy (semaglutide) are starting to get back on track. Novo’s semaglutide cut the risk of ...Fri, 30 Aug 2024 04:48:00 GMTFiercePharmahttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a1308c176924765bc0b9fd9e2a4382f&url=https%3a%2f%2fwww.msn.com%2fen-us%2fhealth%2fother%2fwegovy-pill-sales-smash-forecasts-sending-novo-nordisk-stock-7-higher%2far-AA22uyNu&c=13374348377455035027&mkt=en-usNovo Nordisk raised its outlook for 2026 after a strong performance from its newly launched Wegovy pill.Wed, 06 May 2026 06:59:00 GMTCNBC on MSNhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a1308c176924765bc0b9fd9e2a4382f&url=https%3a%2f%2fseekingalpha.com%2farticle%2f4905051-novo-nordisk-stock-q1-first-fruits-of-labor&c=8157203737026227087&mkt=en-usNovo Nordisk (NVO) surged 25% on Ozempic/Wegovy pill launches, FDA approvals, and low valuation. See here for more details.Thu, 14 May 2026 21:26:00 GMTSeeking Alphahttp://www.bing.com/th?id=ONUT.zHEfbAFtts-F0kUYMkf9mg&pid=Newsw={0}&h={1}&c=1415361024http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a1308c176924765bc0b9fd9e2a4382f&url=https%3a%2f%2fwww.msn.com%2fen-us%2fhealth%2fother%2fa-monthly-weight-loss-shot-why-pfizer-could-topple-lillys-and-novos-glp-1-duopoly%2far-AA21oPz8&c=13317077295949833585&mkt=en-usThere might be room for two titans in the obesity business, but a third player might have a uniquely marketable option.Tue, 21 Apr 2026 05:30:00 GMTThe Motley Fool on MSN